M&A expected to strengthen in 2021 but appetite for healthcare services could wane

Healthcare M&A is expected to make a strong recovery in 2021 driven by corporate acquisitions in key areas such as biopharma, life sciences and diagnostics, according to the third annual Jefferies Healthcare Temperature Check. The report, which is based on the responses from over 500 senior leaders in healthcare, found that both corporate and investors…

You must be a HM Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »